Insider Selling: Amsurg Corp. CEO Unloads 3,000 Shares of Stock (AMSG)
Amsurg Corp. (NASDAQ:AMSG) CEO Christopher Holden sold 3,000 shares of the stock on the open market in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $40.56, for a total value of $121,680.00. Following the completion of the sale, the chief executive officer now directly owns 274,889 shares in the company, valued at approximately $11,149,498. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
A number of analysts have recently weighed in on AMSG shares. Analysts at Cantor Fitzgerald raised their price target on shares of Amsurg Corp. (NASDAQ:AMSG) from $31.00 to $37.00 in a research note to investors on Friday, July 26th. They now have a “hold” rating on the stock. Separately, analysts at Piper Jaffray Cos. raised their price target on shares of Amsurg Corp. (NASDAQ:AMSG) from $32.00 to $36.00 in a research note to investors on Thursday, July 25th. They now have a “neutral” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Amsurg Corp. (NASDAQ:AMSG) in a research note to investors on Wednesday, July 17th. They now have a $41.00 price target on the stock.
Shares of Amsurg Corp. (NASDAQ:AMSG) traded up 0.73% on Friday, hitting $40.01. The stock had a trading volume of 52,533 shares. Amsurg Corp. has a 52 week low of $25.00 and a 52 week high of $41.00. The stock has a 50-day moving average of $38.96 and a 200-day moving average of $36.65. The company has a market cap of $1.293 billion and a price-to-earnings ratio of 18.38.
Amsurg Corp. (NASDAQ:AMSG) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.02. The company had revenue of $269.30 million for the quarter, compared to the consensus estimate of $265.84 million. During the same quarter in the previous year, the company posted $0.51 earnings per share. The company’s revenue for the quarter was up 16.9% on a year-over-year basis. Analysts expect that Amsurg Corp. will post $2.20 EPS for the current fiscal year.
AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (NASDAQ:AMSG) in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.